Extracorporeal Shock Wave Therapy Promotes Osteogenic Differentiation in a Rabbit Osteoporosis Model

Extracorporeal Shock Wave Therapy Promotes Osteogenic Differentiation in a Rabbit Osteoporosis Model

Extracorporeal shock wave therapy (ESWT) has been identified to accelerate bone formation. However, detailed mechanism has not been fully explained. In this study, we found that ESWT promoted osteoblast formation in vitro. Local ESW treatment of femur increased bone formation in vivo. Furthermore, c...

Full description

Bibliographic Details
Main Authors:	Baofeng Li, Renkai Wang, Xianyin Huang, Yongliang Ou, Zhenyu Jia, Shanghui Lin, Ying Zhang, Hong Xia, Bei Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Endocrinology
Subjects:	extracorporeal shock wave osteoblast osteoporosis osteogenic differentiation osteoporosis model SMAD2
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2021.627718/full

Similar Items

PTX3 Effects on Osteogenic Differentiation in Osteoporosis: An In Vitro Study
by: Chiara Greggi, et al.
Published: (2021-05-01)

MiR-27a is Essential for the Shift from Osteogenic Differentiation to Adipogenic Differentiation of Mesenchymal Stem Cells in Postmenopausal Osteoporosis
by: Li You, et al.
Published: (2016-06-01)

Gene co-expression network analysis identifies BRCC3 as a key regulator in osteogenic differentiation of osteoblasts through a β-catenin signaling dependent pathway
by: Lixiong Cai, et al.
Published: (2019-02-01)

Ultra-Small Lysozyme-Protected Gold Nanoclusters as Nanomedicines Inducing Osteogenic Differentiation
by: Li K, et al.
Published: (2020-06-01)

Augmentation of bone mineral acquisition in osteoporotic goat model and in vitro studies by extracorporeal shockwave.
Published: (2006)

SPTBN1 Prevents Primary Osteoporosis by Modulating Osteoblasts Proliferation and Differentiation and Blood Vessels Formation in Bone
by: Xuejuan Xu, et al.
Published: (2021-03-01)

The Osteogenic Potential of Brown Seaweed Extracts
by: Pamela J. Walsh, et al.
Published: (2019-02-01)

Magnesium and Osteoporosis: Current State of Knowledge and Future Research Directions
by: Jeanette A. M. Maier, et al.
Published: (2013-07-01)

Thyroid-stimulating hormone decreases the risk of osteoporosis by regulating osteoblast proliferation and differentiation
by: Tuo Deng, et al.
Published: (2021-03-01)

Osteoporosis: From Molecular Mechanisms to Therapies
by: Chih-Hsin Tang
Published: (2020-01-01)

Mechanisms of osteoporosis development in patients with rheumatoid arthritis
by: Agnieszka Matuszewska, et al.
Published: (2014-02-01)

Influence of Extracellular Vesicles Isolated From Osteoblasts of Patients With Cox-Arthrosis and/or Osteoporosis on Metabolism and Osteogenic Differentiation of BMSCs
by: Tanja Niedermair, et al.
Published: (2020-12-01)

Peptide TQS169 prevents osteoporosis in rats by enhancing osteogenic differentiation and calcium absorption
by: Huan Wang, et al.
Published: (2018-10-01)

POSTMENOPAUSAL OSTEOPOROSIS – AN EXPLORATIVE LITERATURE REVIEW
by: Iulian Ștefan HOLUBIAC, et al.
Published: (2019-12-01)

MicroRNA-200a-3p accelerates the progression of osteoporosis by targeting glutaminase to inhibit osteogenic differentiation of bone marrow mesenchymal stem cells
by: Renfa Lv, et al.
Published: (2019-08-01)

The BMP signaling pathway enhances the osteoblastic differentiation of bone marrow mesenchymal stem cells in rats with osteoporosis
by: Bin Zhao, et al.
Published: (2019-12-01)

NLRP3 Inflammasome: A New Target for Prevention and Control of Osteoporosis?
by: Na Jiang, et al.
Published: (2021-09-01)

The Influence of Strontium on Bone Tissue Metabolism and Its Application in Osteoporosis Treatment
by: Barbara Kołodziejska, et al.
Published: (2021-06-01)

Iron oxides nanoparticles (IOs) exposed to magnetic field promote expression of osteogenic markers in osteoblasts through integrin alpha-3 (INTa-3) activation, inhibits osteoclasts activity and exerts anti-inflammatory action
by: K. Marycz, et al.
Published: (2020-02-01)

Osteoporosis Prevention by Adlay (薏苡 Yì Yǐ: The Seeds of Coix Lachryma-Jobi L. var. ma-yuen Stapf) in a Mouse Model
by: Rong-Sen Yang, et al.
Published: (2013-04-01)

Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation
by: Yoon-Hee Cheon, et al.
Published: (2021-07-01)

The molecular etiology and treatment of glucocorticoid-induced osteoporosis
by: Cheng-Huan Peng, et al.
Published: (2021-01-01)

The effect of low-level estrogen in mandibular bone: An in vivo study
by: Nike Hendrijanti, et al.
Published: (2019-01-01)

Daily intake of β-cryptoxanthin prevents bone loss by preferential disturbance of osteoclastic activation in ovariectomized mice
by: Kakeru Ozaki, et al.
Published: (2015-09-01)

Corticosteriods, 11#beta#-hydroxysteriod dehydrogenase and bone
by: Cooper, Mark Stuart
Published: (2002)

Sanggenon C Stimulates Osteoblastic Proliferation and Differentiation, Inhibits Osteoclastic Resorption, and Ameliorates Prednisone-Induced Osteoporosis in Zebrafish Model
by: Huijuan Wang, et al.
Published: (2018-09-01)

Tabersonine ameliorates osteoblast apoptosis in rats with dexamethasone-induced osteoporosis by regulating the Nrf2/ROS/Bax signalling pathway
by: Xi Sun, et al.
Published: (2020-09-01)

The Development of Molecular Biology of Osteoporosis
by: Yongguang Gao, et al.
Published: (2021-07-01)

The Effects of Tocotrienol on Bone Peptides in a Rat Model of Osteoporosis Induced by Metabolic Syndrome: The Possible Communication between Bone Cells
by: Sok Kuan Wong, et al.
Published: (2019-09-01)

Down-regulation of LECT2 promotes osteogenic differentiation of MSCs via activating Wnt/β-catenin pathway
by: Zhonghua Xu, et al.
Published: (2020-10-01)

LRRC15 promotes osteogenic differentiation of mesenchymal stem cells by modulating p65 cytoplasmic/nuclear translocation
by: Yuejun Wang, et al.
Published: (2018-03-01)

Mesenchymal MACF1 Facilitates SMAD7 Nuclear Translocation to Drive Bone Formation
by: Fan Zhao, et al.
Published: (2020-03-01)

Osteoporosis Treatment with Anti-Sclerostin Antibodies—Mechanisms of Action and Clinical Application
by: Martina Rauner, et al.
Published: (2021-02-01)

Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), miR-21 and miR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast – A Novel Concept for Osteoporosis Treatment: Part 1
by: Marycz K, et al.
Published: (2021-05-01)

STUDIES REGARDING THE IDENTIFICATION OF SOME HISTO-MORPHOLOGICAL PARAMETERS THAT COULD BE USED AS MARKERS FOR BONE MINERALIZATION APPRECISAL IN PIGS – SCIENTIFIC SUPPORT IN OSTEOPOROSIS STUDY
by: GABI DUMITRESCU, et al.
Published: (2007-05-01)

A Review of the Occurrence and Mechanisms of Induction of Osteoporosis Following Spinal Cord Injury
by: Abolfazl Barzegar-Bafrouei, et al.
Published: (2021-03-01)

Suppression of zinc finger protein 467 alleviates osteoporosis through promoting differentiation of adipose derived stem cells to osteoblasts
by: You Li, et al.
Published: (2012-01-01)

MicroRNA-197-3p Inhibits the Osteogenic Differentiation in Osteoporosis by Down-Regulating KLF 10
by: You M, et al.
Published: (2021-01-01)

Glucocorticoids induce osteoporosis mediated by glucocorticoid receptor-dependent and -independent pathways
by: Yu Jiang, et al.
Published: (2020-05-01)

Melatonin promotes bone marrow mesenchymal stem cell osteogenic differentiation and prevents osteoporosis development through modulating circ_0003865 that sponges miR-3653-3p
by: Xudong Wang, et al.
Published: (2021-02-01)

Cannot write session to /tmp/vufind_sessions/sess_iu42ovpiinb78fhrk8ij2nlanv